Dorzolamide Hydrochloride; Timolol Maleate

Drug Usage Statistics, United States, 2006 - 2016

Number of Prescriptions Over Time (2006 - 2016)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2006 185  49
2007 260  75
2008 234  26
2009 203  31
2010 246  43
2011 348  102
Year Rank Change
2012 311  37
2013 262  49
2014 281  19
2015 233  48
2016 200  33

Patient Out-Of-Pocket Cost Over Time (2006 - 2016)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2016)
Metoprolol 74,019,646
Atenolol 26,739,323
Carvedilol 23,338,867
Propranolol Hydrochloride 18,416,025
Nebivolol Hydrochloride 5,686,450
Dorzolamide Hydrochloride; Timolol Maleate (this drug) 2,794,086
Labetalol 2,147,725
Atenolol; Chlorthalidone 1,690,331
Dorzolamide Hydrochloride 1,634,651
Bisoprolol Fumarate 1,473,455
Nadolol 1,453,528
Bisoprolol Fumarate; Hydrochlorothiazide 1,114,559

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Cosopt
  • Cosopt PF
  • Dorzolamide Hydrochloride And Timolol Maleate
Generic Drug Synonyms and Salts
  • Dorzolamide Hydrochloride; Timolol Maleate; Brimonidine Tartrate
  • Dorzolamide Hydrochloride; Timolol Maleate; Latanoprost
  • Timolol Maleate; Dorzolamide Hydrochloride
  • Dorzolamide Hydrochloride; Timolol Maleate

FDA Approval Information

Established Pharmacologic Class (EPC): Carbonic Anhydrase Inhibitor, beta-Adrenergic Blocker
Initial FDA approval date: 4/7/1998
First FDA applicant: Rx
First dosage form: Solution/Drops (ophthalmic)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2006-2016. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 19.0. Read more about the ClinCalc DrugStats database.

Search

Related Links

Follow Us!

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

Learning from notecards is so 1900s... Quickly learn drug therapy with our HD videos. The Top 250 Drugs by ClinCalc Academy
©2018 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Jul 19, 2018
Back to Top
Top